Immune-mediated neuropathies: pathophysiology and management

A Shastri, A Al Aiyan, U Kishore… - International journal of …, 2023 - mdpi.com
Dysfunction of the immune system can result in damage of the peripheral nervous system.
The immunological mechanisms, which include macrophage infiltration, inflammation and …

Clinical presentation and management strategies of cardiovascular autonomic dysfunction following a COVID‐19 infection–A systematic review

D Reis Carneiro, I Rocha, M Habek… - European journal of …, 2023 - Wiley Online Library
Background Cardiovascular autonomic dysfunction may reportedly occur after a coronavirus‐
disease‐2019 (COVID‐19) infection, but the available evidence is scattered. Here we …

Miller Fisher syndrome: an updated narrative review

CM Noioso, L Bevilacqua, GM Acerra… - Frontiers in …, 2023 - frontiersin.org
Introduction Miller Fisher syndrome (MFS) is considered a rare variant of Guillain-Barré
syndrome (GBS), a group of acute-onset immune-mediated neuropathies characterized by …

[HTML][HTML] Therapeutic approaches to the neurologic manifestations of COVID-19

EL Graham, IJ Koralnik, EM Liotta - Neurotherapeutics, 2022 - Elsevier
As of May 2022, there have been more than 527 million infections with severe acute
respiratory disease coronavirus type 2 (SARS-CoV-2) and over 6.2 million deaths from …

Guillain-Barre syndrome following COVID-19 vaccines: A review of literature

M Yu, S Nie, Y Qiao, Y Ma - Frontiers in immunology, 2023 - frontiersin.org
Objective This study aimed to retrospectively analyze reported Guillain–Barré syndrome
(GBS) cases that occurred after COVID-19 vaccination. Methods Case reports of GBS …

[HTML][HTML] Guillain-Barré syndrome after COVID-19 vaccination: A systematic review and analysis of case reports

MT Abuawwad, MJJ Taha, AJ Taha, YA Kozaa… - Clinical Neurology and …, 2024 - Elsevier
Abstract Introduction Cases of Guillain-Barré Syndrome (GBS) have been believed to be
associated with the novel COVID-19 infection, and also with the following vaccines …

Guillain-Barré syndrome and COVID-19 vaccines: focus on adenoviral vectors

P Rzymski - Frontiers in Immunology, 2023 - frontiersin.org
COVID-19 vaccination is a life-saving intervention. However, it does not come up without a
risk of rare adverse events, which frequency varies between vaccines developed using …

[HTML][HTML] Long COVID definition, symptoms, risk factors, epidemiology and autoimmunity: a narrative review

P Kozłowski, A Leszczyńska, O Ciepiela - American Journal of Medicine …, 2024 - Elsevier
The virus called SARS-CoV-2 emerged in 2019 and quickly spread worldwide, causing
COVID-19. It has greatly impacted on everyday life, healthcare systems, and the global …

The onset of de novo autoantibodies in healthcare workers after mRNA based anti-SARS-CoV-2 vaccines: a single centre prospective follow-up study

MC Sacchi, C Pelazza, M Bertolotti, L Agatea… - …, 2023 - Taylor & Francis
Nowadays, data concerning the risk of autoimmune disease after SARS-CoV-2 (COVID-19)
vaccination is controversial. The aim of this single centre prospective follow-up study was to …

COVID‐19 as a trigger of Guillain‐Barré syndrome: A review of the molecular mechanism

M Malekpour, S Khanmohammadi… - Immunity …, 2023 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) caused a pandemic with
serious complications. After coronavirus disease 2019 (COVID‐19), several post‐acute …